1. Klein, G. (1973). Epstein–Barr virus (EBV)-induced transformation of human lymphoid cells and immunosurveillance against lymphoma development. Annales d’Immunologie (Paris), 124, 391–405.
2. World Health Organization (1987) Genital human papillomavirus infections and cancer: memorandum from a WHO meeting. Bulletin of the World Health Organization 65: 817–827
3. Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., et al. (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. The New England Journal of Medicine, 353, 2654–2666.
4. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., et al. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313, 1960–1964.
5. Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., et al. (2008). Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Journal of Clinical Oncology, 26, 4410–4417.